FDA
approval
· 2022-01-24
FDA Approved: RUKOBIA — Supplemental Application (ViiV Healthcare Company)
Summary
FDA approved a supplemental application for Rukobia (fostemsavir tromamine) from ViiV Healthcare Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RUKOBIA (FOSTEMSAVIR TROMETHAMINE)